Skip to main content
SpringerLink
Log in

Central α-adrenergic systems as targets for hypotensive drugs

  • Chapter
  • First Online:
Reviews of Physiology, Biochemistry and Pharmacology, Volume 81

Part of the book series: Reviews of Physiology, Biochemistry and Pharmacology ((REVIEWS,volume 81))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aars, H.: Effects of clonidine on aortic diameter and aortic baroreceptor activity: Eur. J. Pharmacol. 20, 52–59 (1972)

    Google Scholar 

  • Ahlquist, R.P.: Study of adrenotropic receptors. Am. J. Physiol. 153, 586–600 (1948)

    Google Scholar 

  • Alexander, R.S.: Tonic and reflex functions of medullary sympathetic cardiovascular centers. J. Neurophysiol. 9, 205–217 (1946)

    Google Scholar 

  • Andén, N.E., Corrodi, H., Fuxe, K., Hökfelt, T., Rydin, C., Svensson, T.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci. 9, 513–523 (1970)

    Google Scholar 

  • Andén, N.E., Dahlström, A., Fuxe, K., Larsson, K., Olson, L., Ungerstedt, U.: Ascending monoamine neurons to the telencephalon and diencephalon. Acta Physiol. Scand. 67, 313–326 (1966)

    Google Scholar 

  • Andén, N.E., Engel, J., Rubenson, A.: Mode of action of L-DOPA on central noradrenaline mechanism. Naunyn Schmiedebergs Arch. Pharmacol. 273, 1–10 (1972)

    Google Scholar 

  • Andén, N.E., Grabowska, M., Strömbom, U.: Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn Schmiedebergs Arch. Pharmacol. 292, 43–52 (1976)

    Google Scholar 

  • Antonaccio, M.J., Robson, R.D., Burrell, R.: Effects of clonidine on baroreceptor function in anaesthetized dogs. Eur. J. Pharmacol. 30, 6–14 (1975)

    Google Scholar 

  • Antonaccio, M.J., Robson, R.D., Kerwin, L.: Evidence for increased vagal tone and enhancement of baroreceptor reflex activity after xylazine (2-(2, 6-Dimethylphenyla-mino)-4-H-5, 6-dihydro-l, 3-thiazine) in anesthetized dogs. Eur. J.Pharmacol. 23, 311–315 (1973)

    Google Scholar 

  • Ariëns, E.J.: Medical Chemistry, Molecular Pharmacology. New York-London: Academic Press, Vol. I, p. 145/169

    Google Scholar 

  • Autret, A.M., Schmitt, H., Fénard, S., Péillot, N.: Comparison of haemodynamic effects of α-sympathomimetic drugs. Eur. J. Pharmacol. 13, 208–217 (1971)

    Google Scholar 

  • Baum, T., Shropshire, A.T.: Studies on the centrally mediated hypotensive activity of guanabenz. Eur. J. Pharmacol. 37, 31–44 (1976)

    Google Scholar 

  • Baum, T., Shropshire, A.T., Rowles, G., van Pelt, R., Fernandez, S.P., Eckfeld, D., Gluckmann, M.J.: General pharmacological actions of the antihypertensive agent 2, 6-dichlorbenzylidene aminoguanidine acetate (Wy-8678). J. Pharmacol. Exp. Ther. 171, 276–287 (1970)

    Google Scholar 

  • Baum, T., Shropshire, A.T., Varner, L.L.: Contribution of the central nervous system to the action of several antihypertensive agents (methyldopa, hydralazine and guanethi-dine). J. Pharmacol. Exp. Ther. 182, 135–144 (1972)

    Google Scholar 

  • Bentley, G.A., Li, D.M.F.: Studies of the new hypotensive effect of 2-(2, 6 dichlorpheny-lamino)-2-imidazoline hydrochloride (St 155, Catapresan). Eur. J. Pharmacol. 4, 124–134 (1968)

    Google Scholar 

  • Bock, K.D., Merguet, P., Heimsoth, V.H.: Effect of clonidine on regional blood flow and its use in the treatment of hypertension. In: Hypertension: Mechanisms and Management. Onesti, G., Kim, K.E., Moyer, J.H. (eds.) New York: Grune & Stratton 1973 pp. 395–403

    Google Scholar 

  • Bogaievsky, D., Bogaievsky, Y., Tsoucaris-Kupfer, D., Schmitt, D.: Blockade of the central hypotensive effect of clonidine by α-adrenoceptor antagonists in rats, rabbits and dogs. Clin. Exp. Pharmacol. Physiol. 1, 527–534 (1974)

    Google Scholar 

  • Boissier, J.R., Giudicelli, J.F., Fichelle, J., Schmitt, H., Schmitt, H.: Cardiovascular effects of 2-(2, 6-dichlorphenylamino)-2-imidazoline-hydrochloride (St 155). I. Peripheral sympathetic system. Eur. J. Pharmacol. 2, 333–339 (1968)

    Google Scholar 

  • Bolme, P., Corrodi, H., Fuxe, K.: Possible mechanisms of the hypotensive action of 2, 6-dichlorobenzylidene aminoguanidine: evidence for central noradrenaline receptor stimulation. Eur. J. Pharmacol. 23, 175–182 (1973)

    Google Scholar 

  • Bolme, P., Corrodi, H., Fuxe, K., Hökfelt, T., Lidbrink, P., Goldstein, M.: Possible involve-ment of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxan and yohimbine. Eur. J. Pharmacol. 28, 89–94 (1974)

    Google Scholar 

  • Bolme, P., Fuxe, K.: Pharmacological studies on the hypotensive effects of clonidine. Eur. J. Pharmacol. 13, 168–174 (1971)

    Google Scholar 

  • Bousquet, P., Guertzenstein, P.G.: Localization of the central cardiovascular action of clonidine. Br. J. Pharmacol. 49, 573–579 (1973)

    Google Scholar 

  • Boyajy, L.D., Manning, R., Mc.Intosh, R., Schaefer, F., Herzig, M., Schaaf, J., Trapold, J.H.: Cardiovascular effects of 2-(2, 6-dichlorphenyl)-5,6-dihydroimidazo-(2, 1-b)-thiazole hydrobromide (44-549). Volunteer Abstract No. 162. 5th Int. Congr. Pharmacol., San Francisco, 1972

    Google Scholar 

  • Braestrup, C.: Effects of phenoxybenzamine, aceperone and clonidine on the level of 3-methoxy-4-hydroxy-phenylglycol (MOPEG) in rat brain. J. Pharm. Pharmacol. 26, 139–141 (1974)

    Google Scholar 

  • Bream, J.H., Lauener, H., Picard, C.W., Scholtysik, G., White, T.G.: Substituted phenyl-acetylguanidines: anew class of antihypertensive agents. Arzneim. Forsch. 25, 1477–1482 (1975)

    Google Scholar 

  • Brugger, A., Salva, J.A., Sopena, M., Oliver, R.: Estudio experimental sobre el mecanismo de accion del clorhydrato de 2-(2, 6 diclorofenilamino)-2-imidazolina (St 155). Rev. Exp. Fisiol. 25, 233–237 (1969)

    Google Scholar 

  • Brunner, H., Hedwall, P.R., Maître, L., Meier, M.: Antihypertensive effects of alphamethy-lated catecholamine analogues in the rat. Br. J. Pharmacol. 30, 108–122 (1967)

    Google Scholar 

  • Butcher, L.L., Eastgate, S.M., Hodge, G.K.: Evidence that punctate intracerebral administration of 6-hydroxy-dopamine fails to produce selective neuronal degeneration. Comparison with copper sulfate and factors governing the deportment of fluids injected into brain. Naunyn Schmiedebergs Arch. Pharmacol. 285, 31–70 (1974)

    Google Scholar 

  • Carlsson, A., Lindquist, M.: In-vivo decarboxylation of α-methyl DOPA and α-methyl dopamine (3-hydroxytyramine). Acta Physiol. Scand. 54, 87–94 (1962)

    Google Scholar 

  • Chalmers, J.P., Reid, J.L.: Participation of central noradrenergic neurons in arterial baro-receptor reflexes in the rabbit. A study with intracisternally administered 6-hydroxy-dopamine. Circ. Res., 31, 789–804 (1972)

    Google Scholar 

  • Chamberlain, D.A., Howard, H.: Guanethidine and methyldopa: A haemodynamic study. Br. Heart J. 26, 528–536 (1964)

    Google Scholar 

  • Constantine, J.W., McShane, W.K.: Analysis of the cardiovascular effects of 2-(2, 6-dichlorphenylamino)-2-imidazoline hydrochloride (Catapres). Eur. J. Pharmacol. 4, 109–123 (1968)

    Google Scholar 

  • Cosnier, D., Duchene-Marullaz, P., Grimal, J., Rispat, G., Streichenberger, G.: Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. I Action on blood pressure and heart rate. Arzneim. Forsch. 25, 1557–1561 (1975a)

    Google Scholar 

  • Cosnier, D., Labrid, C., Rispat, G., Streichenberger, G.: Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. II Action on cardiac contraction, circulatory parameters, autonomic receptors and dimesis. Arzneim. Forsch. 25, 1802–1806 (1975b)

    Google Scholar 

  • Cottle, M.K.: Degeneration studies of primary afferents of IX th and Xth cranial nerves in the cat. J. Comp. Neurol. 122, 329–345 (1964)

    Google Scholar 

  • Coupar, J.M., Kirby, M.J.: The effect of clonidine on human isolated smooth muscle. Eur. J. Pharmacol. 17, 50–58 (1972)

    Google Scholar 

  • Crill, W.E., Reis, D.J.: Distribution of carotid sinus and depressor nerves in cat brain stem. Am. J. Physiol. 214, 269–276 (1968)

    Google Scholar 

  • Csongrady, A., Kobinger, W.: Investigations into the positive inotropic effect of clonidine in isolated hearts. Naunyn Schmiedebergs Arch. Pharmacol. 282, 123–128 (1974)

    Google Scholar 

  • Davies, D.S., Reid, J.L. (eds.): Central Action of Drugs in Blood Pressure Regulation. Tunbridge Wells: Pitman Medical Publishing (1975)

    Google Scholar 

  • Day, M.D., Rand, M.J.: Some observations on the pharmacology of α-methyldopa. Br. J. Pharmacol. 22, 72–86 (1964)

    Google Scholar 

  • Day, M.D., Roach, A.G., Withing, R.L.: The mechanism of the antihypertensive action of α-methyl-DOPA in hypertensive rats. Eur. J. Pharmacol. 21, 271–280 (1973)

    Google Scholar 

  • Deck, R., Oberdorf, A., Kroneberg, G.: Die Wirkung von 2-(2, 6-dichlorphenylamino)-2-imidazolin Hydrochlorid (Clonidin) auf die Kontraktion und die Acetylcholin-Frei-setzung am isolierten, koaxial elektrisch gereizten Meerschweinchenileum. Arzneim. Forsch. 21, 1580–1584 (1971)

    Google Scholar 

  • Dhawan, B.N., Johri, M.B., Singh, G.B., Srimal, R.C., Viswesaram, D.: Effect of clonidine on the excitability of vasomotor loci in the cat. Br. J. Pharmacol. 54, 17–21 (1975)

    Google Scholar 

  • Djawan, S., Mlczoch, J., Niederberger, M., Penner, E., Grabner, G.: Ein neues Antihyper-tensivum der Imidazolin-Reihe: 5-Fluor-2-methyl-2-imidazol-idinylidenbenzamin Monohydrochlorid (St 600, Flutonidin); II. Hämodynamische Untersuchungen in Ruhe und unter Belastung. Wien. Klin. Wochenschr. 88, 199–206 (1976)

    Google Scholar 

  • Doba, N., Reis, D.: Role of central and peripheral adrenergic mechanisms in neurogenic hypertension produced by brainstem lesions in rat. Circ. Res. 34, 293–301. (1974)

    Google Scholar 

  • Dollery, C.T., Davies, D.S., Draffan, G.H., Dargie, H.J., Dean, C.R., Reid, J.L., Clare, R.A., Murray, S.: Clinical pharmacology and pharmacokinetics of clonidine, Clin. Pharmacol. Ther. 19, 11–17 (1976)

    Google Scholar 

  • Dollery, C.T., Reid, J.L.: Central noradrenergic neurones and the cardiovascular actions of clonidine in the rabbit. Br. J. Pharmacol. 47, 206–216 (1973)

    Google Scholar 

  • Farnebo, L.O., Hamberger, B.: Drug-induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta Physiol. Scand. [Suppl.] 371, 35–44 (1971)

    Google Scholar 

  • Farnebo, L.O., Hamberger, B.: Catecholamine release and receptors in brain slices. In: Frontiers in Catecholamine Research. Usdin, E., Snyder, S.H. (eds.). New York: Pergamon Press 1973, pp. 589–593

    Google Scholar 

  • Finch, L.: The cardiovascular effects of intraventricular clonidine and Bay 1470 in conscious hypertensive cats. Br. J. Pharmacol. 52, 333–338 (1974)

    Google Scholar 

  • Finch, L.: The central hypotensive action of clonidine and Bay 1470 in cats and rats. Clin. Sci. Mol. Med. 48, 273s–278s (1975)

    Google Scholar 

  • Finch, L., Haeusler, G.: Further evidence for a central hypotensive action of α-methyl-DOPA in both the rat and the cat. Br. J. Pharmacol. 47, 217–228 (1973)

    Google Scholar 

  • Finch, L., Hersom, A., Hicks, P.: Studies on the hypotensive action of α-methyldopa-mine. Br. J. Pharmacol. 54, 445–451 (1975)

    Google Scholar 

  • Folkow, B., Neil, E.: Circulation. New York-London-Toronto: Oxford U. Pr.

    Google Scholar 

  • Folkow, B., Nilsson, N.J., Yonce, L.R.: Effect of “diving” on cardiac output in ducks. Acta Physiol. Scand. 70, 347–361 (1967)

    Google Scholar 

  • Franz, D.N., Hare, B.D., Neumayr, R.J.: Reciprocal control of sympathetic preganglionic neurons by monoaminergic, bulbospinal pathways and a selective effect of clonidine. In: Recent Advances in Hypertension. Milliez, P., Safar, M. (eds.). Reims: Boehringer Ingelheim 1975, Vol. I. pp. 85–96

    Google Scholar 

  • Fuxe, K.: The distribution of monoamine terminals in the central nervous system. Acta Physiol. Scand. 64 (Suppl. 247) (1965)

    Google Scholar 

  • Fuxe, K., Hökfelt, T., Bolme, P., Goldstein, M., Johansson, O., Jonsson, G., Lidbrink, P., Ljungdahl, A., Sachs, Ch.: The topography of central catecholamine pathways in relation to their possible role in blood-pressure control. In: Central Action of Drugs in Blood Pressure Regulation. Davies, D.S., Reid, J.L. (eds.). Tunbridge Wells: Pitman Medical Publishing 1975, pp. 8–22

    Google Scholar 

  • Gagnon, D.J., Melville, K.I.: Possible dual role of noradrenaline in cardiovascular responses mediated by the central nervous system. Can. J. Physiol. Pharmacol. 46, 595–599 (1968)

    Google Scholar 

  • Gillespie, L., Jr., Oates, J.A., Crout, J.R., Sjoerdsma, A.: Clinical and chemical studies with α-methyl-dopa in patients with hypertension. Circulation 25, 281–291 (1962)

    Google Scholar 

  • Giudicelli, R., Beauvallet, M., Chabrier, P., Najer, H., Delépine, M.M.: Sur Faction vasculaire de quelques amino-2-oxazolines N-substituées. C. R. Acad. Sci. (Paris) 247, 2494–2497 (1958)

    Google Scholar 

  • Goldberg, L.J., Da Costa, F.M., Ozaki, M.: Actions of the decarboxylase inhibitor, α-methyl-3, 4-dihydroxyphenylolamine in the dog. Nature 188, 502–504 (1960)

    Google Scholar 

  • Grabner, G., Michalek, P., Pokorny, D., Vormittag, E.: Klinische und experimentelle Untersuchungen mit der neuen blutdrucksenkenden Substanz 2-(2, dichlorphenyl-amino)-2-imidazolinhydrochlorid. Arzneim. Forsch. 16, 1174–1179 (1966)

    Google Scholar 

  • Grabowska, M., Andén, N.E.: Noradrenaline synthesis and utilisation: Control by nerve impulse flow under normal conditions and after treatment with alpha-adrenoceptor blocking agents. Naunyn Schmiedebergs Arch. Pharmacol. 292, 53–58 (1976)

    Google Scholar 

  • Graubner, W., Wolf, M.: Kritische Betrachtungen zum Wirkungsmechanismus des 2-(2, 6-dichlorphenylamino)-2-imidazolinhydrochlorid. Arzneim. Forsch. 16, 1055–1058 (1966)

    Google Scholar 

  • Haeusler, G.: Activation of the central pathway of the baroreceptor reflex, a possible mechanism of the hypotensive action of clonidine. Naunyn Schmiedebergs Arch. Pharmacol. 278, 231–246 (1973)

    Google Scholar 

  • Haeusler, G.: Further similarities between the action of clonidine and a central activation of the depressor baroreceptor reflex. Naunyn Schmiedebergs Arch. Pharmacol. 285, 1–14 (1974a)

    Google Scholar 

  • Haeusler, G.: Clonidine induced inhibition of sympathetic nerve activity: no indication for a central presynaptic or an indirect sympathomimetic mode of action. Naunyn Schmiedebergs Arch. Pharmacol. 286, 97–111 (1974b)

    Google Scholar 

  • Haeusler, G.: Cardiovascular regulation by central adrenergic mechanisms and its alteration by hypotensive drugs. Circ. Res. 36/37 (Suppl. 1), 223–232 (1975)

    Google Scholar 

  • Haeusler, G.: Inhibition of the preganglionic sympathetic neurone through spinal α-adrenoceptors. Naunyn Schmiedebergs Arch. Pharmacol. 293, R 15 (1976)

    Google Scholar 

  • Haeusler, G., Finch, L.: On the nature of the central hypotensive effect of clonidine on alpha-methyldopa. Reunion Commune de la Deutsche Pharmakologische Gesellschaft et de l'Association Francaise des Pharmacologistes, Paris, 25–27 September 1972, Abstracts, pp. 16–17

    Google Scholar 

  • Haeusler, G., Lewis, P.: The baroreceptor reflex and its relations to central adrenergic mechanisms. In: Recent Advances in Hypertension. Milliez, P., Safar, M.(eds.). Reims: Boehringer Ingelheim 1975, pp. 17–26

    Google Scholar 

  • Hamperl, H., Heller, H.: Die Ausbreitung intracisternal injizierter Stoffe im Liquorraum. Naunyn Schmiedebergs Arch. Pharmacol. 173, 283–290 (1933)

    Google Scholar 

  • Heise, A., Kroneberg, G.: Alpha-sympathetic receptor stimulation in the brain and hypotensive action of α-methyl-DOPA. Eur. J. Pharmacol. 17, 315–317 (1972)

    Google Scholar 

  • Heise, A., Kroneberg, G., Schlossmann, K.: α-sympathicomimetische Eigenschaften als Ursache der blutdrucksteigernden und blutdrucksenkenden Wirkung von BAY 1470 (2-(2,6-xylidino)-5,6-dihydro-4H-l, 3-thiazinhydrochlorid). Naunyn Schmiedebergs Arch. Pharmacol. 268, 348–360 (1971)

    Google Scholar 

  • Heller, H.: Über die zentrale Blutdruckwirkung des Adrenalins, Naunyn Schmiedebergs Arch. Pharmacol. 173, 291–300 (1933)

    Google Scholar 

  • Henning, M.: Blood pressure and noradrenaline levels after treatment with α-methyldopa, α-methyldopamine and α-methyl-m-tyrosine. J. Pharm. Pharmacol. 19, 775–779 (1967)

    Google Scholar 

  • Henning, M.: Studies on the mode of action of α-methyldopa. Acta Physiol. Scand. (Suppl.) 322 1–37 (1969a)

    Google Scholar 

  • Henning, M.: Interaction of DOPA Decarboxylase Inhibitors with the effect of α-methyl-dopa on blood pressure and tissue monoamines in rats. Acta Pharmacol. Toxicol. 27, 135–148 (1969b)

    Google Scholar 

  • Henning, M., Rubenson, A.: Evidence that the hypotensive action of α-methyl-DOPA is mediated by central actions of methylnoradrenaline. J. Pharm. Pharmacol. 23, 407–411 (1971)

    Google Scholar 

  • Henning, M., Stock, G., Trolin, G.: Circulatory effects of clonidine after pre-hypotha-lamic section in the rat. Acta Pharmacol. Toxicol. 38, 376–381 (1976)

    Google Scholar 

  • Henning, M., van Zwieten, P.A.: Central hypotensive effect of α-methyl-DOPA. J. Pharm. Pharmacol. 19, 403–405 (1967)

    Google Scholar 

  • Henning, M., van Zwieten, P.A.: Central hypotensive action of α-methyl-DOPA. J. Pharm. Pharmacol. 20, 409–417 (1968)

    Google Scholar 

  • Heymans, C., Neil, E.: Reflexogenic Areas of the Cardiovascular System. London: Churchill 1958, p. 73

    Google Scholar 

  • Hoefke, W., Kobinger, W.: Pharmakologische Wirkung des 2-(2,6-dichlorphenylamino)-2-imidazolinhydrochlorids, einer neuen, antihypertensiven Substanz. Arzneim. Forsch. 16, 1038–1050 (1966)

    Google Scholar 

  • Höefke, W., Walland, A., Kobinger, W.: Relationship between activity and structure in derivatives of clonidine. Arzneim. Forsch. 25, 786–793 (1975)

    Google Scholar 

  • Höefke, W., Warnke-Sachs, E.: Influence of desmethylimipramine on the hypotensive effect of clonidine. Arzneim. Forsch. 24, 1046–1047 (1974)

    Google Scholar 

  • Hökfelt, T., Fuxe, K., Goldstein, M., Johansson, O.: Evidence for adrenaline neurons in the rat brain. Acta Physiol. Scand. 89, 286–288 (1973)

    Google Scholar 

  • Hökfelt, B., Hedeland, H., Dymling, J.-F.: Studies on catecholamines, renin and aldoste-rone following catapresan R (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochlor-ide) in hypertensive patients. Eur. J. Pharmacol. 10, 389–397 (1970)

    Google Scholar 

  • Hökfelt, B., Hedeland, H., Hansson, B.-G.: The effects of clonidine and penbutolol, respectively on catecholamines in blood and urine, plasma renin activity and urinary aldosterone in hypertensive patients. Arch. Int. Pharmacodyn. 213, 307–321 (1975)

    Google Scholar 

  • Holtz, P., Palm, D.: Brenzkatechinamine und andere sympathicomimetische Amine. Rev. Physiol. Biochem. Pharmacol. 58 (1966)

    Google Scholar 

  • Hoyer, J., van Zwieten, P.A.: The centrally induced fall in blood pressure after the infusion of amphetamine and related drugs into the vertebral artery of the cat. J. Pharm. Pharmacol. 23, 892–893 (1971)

    Google Scholar 

  • Hoyer, J., van Zwieten, P.A.: The central hypotensive action of amphetamine, ephedrine, phentermine, chlorphentermine and fenfluramine. J. Pharm. Pharmacol. 24, 452–458 (1972)

    Google Scholar 

  • Hukuhara, T., Jr., Otsuka, Y., Takeda, R., Sakai, F.: Die zentralen Wirkungen des 2-(2, 6-dichlorphenylamino)-2-imidazolin-hydrochlorids. Arzneim. Forsch. 18, 1147–1153 (1968)

    Google Scholar 

  • Humphrey, D.R.: Neuronal activity in the medulla oblongata of cat evoked by stimulation of the carotid sinus nerve. In: Baroreceptors and Hypertension, Proceedings of an Internat. Sympos. Held at Dayton, Ohio. Kezdi, P. (ed.). Oxford: Pergamon Press 1967, pp. 131–167

    Google Scholar 

  • Iggo, A., Vogt, M.: Preganglionic sympathetic activity in normal and in reserpine-treated cats. J. Physiol. (Lond.) 150, 114–133 (1960)

    Google Scholar 

  • Ingenito, A.J., Barrett, M., Procita, A.: Centrally mediated peripheral hypotensive effect of α-methyldopa. J. Pharmacol. Exp. Ther. 175, 593–599 (1970)

    Google Scholar 

  • Ito, A., Schanberg, S.M.: Maintenance of tonic vasomotor activity by alpha and beta adrenergic mechanisms in medullary cardiovascular centers. J. Pharmacol. Exp. Ther. 189, 392–404 (1974)

    Google Scholar 

  • Jacobs, F., Werner, U., Schumann, H.J.: Zum Mechanismus der antihypertensiven Wir-kung des Oxazolin-Derivates Bay a 6781. Arzneim. Forsch. 22, 1124–1126 (1972)

    Google Scholar 

  • Jaju, B.P., Tangri, K.K., Bhargava, K.P.: Central vasomotor effects of α-methyl-DOPA. Can. J. Physiol. Pharmacol. 44, 687–690 (1966)

    Google Scholar 

  • Jen, T., Dienel, B., Bowman, H., Petta, J., Helt, A., Loev, B.: Amidines. 2.A new class of antihypertensive agents. 1, 2, 3, 5-tetrahydroimidazo (2, 1-b) quinazolines. J. Med. Chem. 15, 727–731 (1972)

    Google Scholar 

  • Jen, T., van Hoeven, H., Groves, W., Mc Lean, R., Loev, B.: Amidines and related Compounds. 6. Studies on structure-activity relationship of antihypertensive and anti-secretary agents related to clonidine. J. Med. Chem. 18, 90–99 (1975)

    Google Scholar 

  • de Jong, W.: Noradrenaline: central inhibitory control of blood pressure and heart rate. Eur. J. Pharmacol. 29, 179–181 (1974)

    Google Scholar 

  • de Jong, W., Nijkamp, F.P., Bohus, B.: Role of noradrenaline and serotonin in the central control of blood pressure in normotensive and spontaneous by hypertensive rats. Arch. Int. Pharmacodyn. 213, 272–284 (1975)

    Google Scholar 

  • Julius, S., Esler, M. (eds.): The Nervous System in Arterial Hypertension. Springfield: Charles C. Thomas 1976

    Google Scholar 

  • Kaneko, Y., Mc Cubbin, J.W., Page, I.H.: Mechanism by which serotonin, norepinephrine and reserpine cause central vasomotor inhibition. Circ. Res. 8, 1228–1234 (1960)

    Google Scholar 

  • Karppanen, H.O., Westermann, E.: Increased production of cyclic AMP in gastric tissue by stimulation of histamine2 (H2)-receptors. Naunyn Schmiedebergs Arch. Pharmacol. 279, 83–87 (1973)

    Google Scholar 

  • Katie, F., Lavery, H., Lowe, R.D.: The central action of clonidine and its antagonism. Br. J. Pharmacol. 44, 779–787 (1972)

    Google Scholar 

  • Kho, T.L., Schalekamp, M.A.D.H., Zaal, G.A., Wester, A., Birkenhäger, W.H.: Comparison between the effects of St 600 and catapres. Arch. Int. Pharmacodyn. 214, 347–350 (1975)

    Google Scholar 

  • Kirkendall, W.M., Wilson, W.R.: Pharmacodynamics and clinical use of guanethidine, bretylium and methyldopa. Am. J. Cardiol. 9, 107–115 (1962)

    Google Scholar 

  • Klevans, L.R., Kepner, K., Kovacs, J.L.: Role of forebrain in clonidine-induced suppression of cardiovascular responses, Eur. J. Pharmacol. 24, 262–265 (1973)

    Google Scholar 

  • Klupp, H., Knappen, F., Otsuka, Y., Streller, J., Teichmann, H.: Effects of clonidine on central sympathetic tone. Eur. J. Pharmacol. 10, 225–229 (1970)

    Google Scholar 

  • Kobinger, W.: Über den Wirkungsmechanismus einer neuen antihypertensiven Substanz mit Imidazolinstruktur. Naunyn Schmiedebergs Arch. Pharmacol. 258, 48–58 (1967)

    Google Scholar 

  • Kobinger, W.: Pharmacologic basis of the cardiovascular actions of clonidine. In: Hypertension: Mechanisms and Management. Onesti, G., Kim, K.E., Moyer, J.H. (eds.). New York: Grune & Stratton 1973, pp. 369–380

    Google Scholar 

  • Kobinger, W.: Medicinal chemistry related to the central regulation of blood pressure. II. Pharmacological part. In: Medicinal Chemistry IV. Maas, J. (ed.). Amsterdam-Oxford-New York: Elsevier Scientific Publishing 1974, pp. 107–120

    Google Scholar 

  • Kobinger, W.: Central cardiovascular actions of clonidine. In: Davies, D., Reid, J.L.: Central Action of Drugs in Blood Pressure Regulation. Tunbridge Wells: Pitman Medical Publishing 1975, pp. 181–193

    Google Scholar 

  • Kobinger, W., Oda, M.: Effects of sympathetic blocking substances on the diving reflex of ducks. Eur. J. Pharmacol. 7, 289–295 (1969)

    Google Scholar 

  • Kobinger, W., Pichler, L.: Evidence for direct α-adrenoceptor stimulation of effector neurons in cardiovascular centers by clonidine, Eur. J. Pharmacol. 27, 151–154 (1974)

    Google Scholar 

  • Kobinger, W., Pichler, L.: The central modulatory effect of clonidine on the cardiode-pressor reflex after suppression of synthesis and storage of noradrenaline. Eur. J. Pharmacol. 30, 56–62 (1975a)

    Google Scholar 

  • Kobinger, W., Pichler, L.: Localization in the CNS of adrenoceptors which facilitate a car-dioinhibitory reflex. Naunyn Schmiedebergs Arch. Pharmacol. 286, 371–377 (1975b)

    Google Scholar 

  • Kobinger, W., Pichler, L.: Investigation into some imidazoline compounds, with respect to peripheral α-adrenoceptor stimulation and depression of cardiovascular centers. Naunyn Schmiedebergs Arch. Pharmacol. 291, 175–191 (1975c)

    Google Scholar 

  • Kobinger, W., Pichler, L.: Centrally induced reduction in sympathetic tone-a postsynaptic α-adrenoceptor stimulating action of imidazolines. Eur. J. Pharmacol. 40, 311–320 (1976)

    Google Scholar 

  • Kobinger, W., Pichler, L.: Pharmacological characterization of B-HT 933 (2-Amino-6-ethyl-4, 5, 7, 8-tetrahydro-6H-oxazolo-|5, 4-d| azepin-dihydrochloride) as a hypotensive agent of the “Clonidine-Type”. Naunyn Schmiedebergs Arch. Pharmacol. 300, 39–46 (1977)

    Google Scholar 

  • Kobinger, W., Walland, A.: Kreislaufuntersuchungen mit 2-(2, 6-dichlorphenylamino)-2-imidazolinhydrochloride. Arzneim. Forsch. 17, 292–300 (1967a)

    Google Scholar 

  • Kobinger, W., Walland, A.: Investigations into the mechanism of the hypotensive effect of 2-(2, 6 dichlorphenylarnino)-2-imidazoline HC1. Eur. J. Pharmacol. 2, 155–162 (1967b)

    Google Scholar 

  • Kobinger, W., Walland, A.: Involvement of adrenergic receptors in central vagus activity. Eur. J. Pharmacol. 16, 120–122 (1971)

    Google Scholar 

  • Kobinger, W., Walland, A.: Evidence for a central activation of a vagal cardiodepressor reflex by clonidine. Eur. J. Pharmacol. 19, 203–209 (1972a)

    Google Scholar 

  • Kobinger, W., Walland, A.: Facilitation of vagal reflex bradycardia by an action of clonidine on central α-receptors. Eur. J. Pharmacol. 19, 210–217 (1972b)

    Google Scholar 

  • Kobinger, W., Walland, A.: Modulating effect of central adrenergic neurones on a vagally mediated cardioinhibitory reflex. Eur. J. Pharmacol. 22, 344–350 (1973)

    Google Scholar 

  • Korner, P.J.: Integrative neural cardiovascular control. Physiological Rev., 51 312–367 (1971)

    Google Scholar 

  • Korner, P.J., Blomberg, P.A., Bobik, A., Tonkin, A.M., Uther, J.B.: Valsalva constrictor reflex in human hypertension and after beta-adrenoceptor blockade in conscious rabbits. Clin. Sci. Mol. Med. (in press) (1976)

    Google Scholar 

  • Korner, P.J., Oliver, J.R., Sleight, P., Chalmers, J.P., Robinson, J.S.: Effects of clonidine on the baroreceptor-heart rate reflex and on single aortic baroreceptor fibre discharge. Eur. J. Pharmacol. 28, 189–198 (1974)

    Google Scholar 

  • Kroneberg, H.G.: Pharmakologie der blutdrucksenkenden Arzneimittel. Verh. Dtsch. Ges. Kreislaufforsch. 28/29 172–184 (1962/63)

    Google Scholar 

  • Kroneberg, G., Oberdorf, A., Hoffmeister, F., Wirth, W.: Zur Pharmakologie von 2-(2, 6-dimethylphenylamino)-4H-5, 6-dihydro-l, 3-thiazin (Bayer 1470), eines Hemmstof-fes adrenergischer und cholinergischer Neurone, Naunyn Schmiedebergs Arch. Pharmacol. 256, 257–280 (1967)

    Google Scholar 

  • Kündig, H., Monnier, H., Levin, N.W., Charlton, R.W.: Mechanism of action of St 155 on the blood pressure in rats. Arzneim. Forsch. 17, 1440–1444 (1967)

    Google Scholar 

  • Langer, S.Z., Enero, M.A., Adler-Graschinsky, W., Dubocovich, M.L., Celuchi, S.M.: Pre-synaptic regulatory mechanisme for noradrenaline release by nerve stimulation. In: Central Action of Drugs in Blood Pressure Regulations, Davies, D., Reid, J.L. (eds.). Tunbridge Wells: Pitman Medical Publishing 1975, pp. 133–150

    Google Scholar 

  • Laubie, M., Schmitt, H.: Effects hemodynamiques du St 155, 2-(2, 6-dichlorophenyla-mino)-2-imidazoline hydrochloride, chez le chien hypertendu. Arch. Int. Pharma-codyn. 179, 23–35 (1969)

    Google Scholar 

  • Li, D.M.P., Bentley, G.A.: The effect of St 155 on the active reflex vasodilatation induced by adrenaline, noradrenaline and veratrine. Eur. J. Pharmacol. 8, 39–46 (1969)

    Google Scholar 

  • Li, D.M.P., Bentley, G.A.: The effect of various antihypertensive drugs on the reflex responses to vasoactive substances. Eur. J. Pharmacol. 12, 24–34 (1970)

    Google Scholar 

  • Lindner, E., Kaiser, J.: Thiamenidine(Hoe 440), a new antihypertensive substance. Arch. Int. Pharmacodyn. 211, 305–325 (1974)

    Google Scholar 

  • Lipsky, J., Mc Allen, R.M., Spyer, K.M.: The sinus nerve and baroreceptor input to the medulla of the cat. J. Physiol. (Lond.) 251, 61–78 (1975)

    Google Scholar 

  • Löfwing, B.: Cardiovascular adjustments induced from the rostral cingulate gyrus. With special reference to sympathoinhibitory mechansims. Act Physiol. Scand. 53, (Suppl. 184) 1–82 (1961)

    Google Scholar 

  • Loeschcke, H.H., Koepchen, H.P.: Versuch zur Lokalisation des Angriffsortes der Atem und Kreislaufwirkung von Novocain im Liquor cerebrospinalis. Pflüegers Arch. 266, 628–641 (1958)

    Google Scholar 

  • Maling, H.M., Cho, A.K., Horakova, Z., Williams, M.A.: The pharmacologic effects of St 155 (Catapres) and related imidazolines in the rat. Pharmacology 2, 337–351 (1969)

    Google Scholar 

  • Maxwell, G.M.: The effects of 2-(2, 6-dichlorphenylamino)-2-imidazoline hydrochloride (catapres) upon the systemic and coronary haemodynamics and metabolism of intact dogs. Arch. Int. Pharmacodyn. 181, 7–14 (1969)

    Google Scholar 

  • McCall, R.B., Gebber, G.L.: Differential effect of baroreceptor reflexes and clonidine on frequency components of sympathetic discharge. Eur. J. Pharmacol. 36, 69–78 (1976)

    Google Scholar 

  • McCubbin, J.W., Kaneko, Y., Page, I.H.: Ability of serotonin and norepinephrine to mimic the central effects of reserpine on vasomotor activity. Circ. Res. 8. 849–858 (1960)

    Google Scholar 

  • Meerman-van Benthem, C.M., van der Meer, K., Mulden, J.J.C., Timmermans, P.B.M.W.M., van Zwieten, P.A.: Clonidine base: evidence for conjugation of both ring systems. Mol. Pharmacol. 11, 667–670 (1975)

    Google Scholar 

  • Merguet, P., Bock, K.D.: Effects of antihypertensive agents on skin and muscle blood flow in man. In: Hypertension: Mechanism and Management. Onesti, G., Kim, K.E., Moyer, J.E. (eds.). New York-London: Grune & Stratton, 1973, pp. 241–250

    Google Scholar 

  • Milliez, P., Safar, M. (eds.): Recent Advances in Hypertension. Monaco 1975. Reims: Boehringer Ingelheim 1975

    Google Scholar 

  • Muir, A.L., Burton, J.L., Lawrie, D.M.: Circulatory effects at rest and exercise of clonidine, an imidazoline derivative with hypertensive properties. Lancet 1969/II, 181–184

    Google Scholar 

  • Mujic, M., van Rossum, J.M.: Comparative pharmacodynamics of sympathomimetic imidazolines; studies on intestinal smooth muscle of the rabbit and the cardiovascular system of the cat. Arch. Int. Pharmacodyn. 155, 432–449 (1965)

    Google Scholar 

  • Muscholl, E.: Autonomic nervous system: Newer mechanisms of adrenergic blockade. Annu. Rev. Pharmacol. 6, 107–128 (1966)

    Google Scholar 

  • Muscholl, E., Maitre, L.: Release by sympathetic stimulation of α-methylnoradrenaline stored in the heart after administration of α-methyldopa. Experientia (Basel) 19, 658–659 (1963)

    Google Scholar 

  • Muscholl, E., Rahn, K.H.: Über den Nachweis und die Bedeutung von α-Methylnoradrenalin im Harn von Hypertonikern bei Verabreichung von α-Methyldopa. Pharmacol. Clin, 1, 19–20 (1968)

    Google Scholar 

  • Nayler, W.G., Price, J.M., Stone, J., Lowe, T.E.: Further observations on the cardiovascular effects of St 155 (Catapres). J. Pharmacol. Exp. Ther. 166, 364–373 (1969)

    Google Scholar 

  • Nayler, W.G., Price, J.M., Swann, J.B., Mc Innes, J., Race, D., Lowe, T.E.: Effect of the hypotensive drug St 155 (Catapres) on the heart and peripheral circulation. J. Pharmacol. Exp. Ther. 164, 45–59 (1968)

    Google Scholar 

  • Nayler, W.G., Rosenbaum, M., Mc Innes, J., Lowe, T.E.: Effect of a new hypotensive drug, St 155, on the systemic circulation. Am. Heart J. 72, 764–770 (1966)

    Google Scholar 

  • Nayler, W.G., Stone, J.: An effect of St 155 (clonidine), 2-(2, 6-dichlorphenylamino)-2-imidazoline hydrochloride, catapres on relationship between blood pressure and heart rate in dogs. Eur. J. Pharmacol. 10, 161–167 (1970)

    Google Scholar 

  • Nolan, P.L., Bentley, G.A.: Studies on orthostatic cardiovascular responses in anaesthetized cats. Clin. exp. Pharmacol. Physiol. (Suppl.) 2, 213–216 (1975)

    Google Scholar 

  • Oates, J.A., Gillespie, L., Udenfriend, S., Sjoerdsma, A.: Decarboxylase inhibition and blood pressure reduction by α-methyl-3, 4-dihydroxy-DL-phenylalanine. Science 131, 1890–1891 (1960)

    Google Scholar 

  • Onesti G., Fernandes, M., Kim, K.E. (eds.).: Regulation of Blood Pressure by the Central Nervous System. New York-San Francisco-London: Grune & Stratton 1976

    Google Scholar 

  • Onesti, G., Schwartz, A.B., Kim, K.E., Paz-Martinez, V., Swartz, CH.: Antihypertensive effect of clonidine. Circ. Res. 28 (Suppl. 2), 53–69 (1971)

    Google Scholar 

  • Onesti, G., Schwartz, A.B., Kim, K.E., Swartz, Ch., Brest, A.N.: Pharmacodynamic effects of a new antihypertensive drug, catapres (St 155). Circulation 39, 219–228 (1969)

    Google Scholar 

  • Paton, W.D.M., Vizi, E.S.: The inhibitory action of noradrenaline and adrenaline on acetyl-choline output by guinea-pig ileum longitudinal muscle strip. Br. J. Pharmacol. 35, 10–28 (1969)

    Google Scholar 

  • Pettinger, W., Horwitz, D., Spector, S., Sjoerdsma, A.: Enhancement by methyldopa of tyramine sensitivity in man. Nature 200, 1107–1108 (1963)

    Google Scholar 

  • Phillippu, A., Demmeler, R., Roensberg, G.: Effects of centrally applied drugs on pressure responses to hypothalamic stimulation. Naunyn Schmiedebergs Arch. Pharmacol. 287, 389–400 (1974)

    Google Scholar 

  • Philippu, A., Heyd, G., Burger, A.: Release of noradrenaline from the hypothalamus in vivo. Eur. J. Pharmacol. 9, 52–58 (1970)

    Google Scholar 

  • Phillippu, A., Przuntek, H., Heyd, G., Burger, A.: Central effects of sympathomimetic amines on the blood pressure. Eur. J. Pharmacol. 15, 200–208 (1971)

    Google Scholar 

  • Philippu, A., Roensberg, W., Przuntek, H.: Effects of adrenergic drugs on pressure responses to hypothalamic stimulation. Naunyn Schmiedebergs Arch. Pharmacol. 278, 373–386 (1973)

    Google Scholar 

  • Pletscher, A.H., Besendorf, H., Bächtold, H.P.: Benzo-a-chinolizine, eine neue Körper-klasse mit Wirkung auf den 5-Hydroxytryptamin — und Noradrenalin-Stoffwechsel des Gehirns. Naunyn Schmiedebergs Arch. Pharmacol. 232, 499–506 (1958)

    Google Scholar 

  • Pletscher, A., Gey, F.: The effect of a new decarboxylase inhibitor on endogenous and exogenous monoamines. Biochem. Pharmacol. 12, 223–228 (1963)

    Google Scholar 

  • Pook, K.H., Stähle, H., Daniel, H.: Strukturuntersuchungen an 2-(Arylimino) imidazoli-dinen und 2-(Arylamino) imidazolinen mit Hilfe der Protonen-und Kohlenstoff-13-Resonanz. Chem. Ber. 107, 2644–2657 (1974)

    Google Scholar 

  • Porter, C.C., Totaro, J.A., Leiby, C.M.: Some biochemical effects of α-methyl-3, 4-dihy-droxyphenylalanine and related compounds in mice. J. Pharmacol. Exp. Ther. 134, 139–145 (1961)

    Google Scholar 

  • Porter, C.C., Watson, L.S., Titus, D.C., Totaro, J.A., Byer, S.S.: Inhibition of DOPA decarboxylase by the hydrazino analogue of α-methyl-DOPA. Biochem. Pharmacol. 11, 1067–1077 (1962)

    Google Scholar 

  • Pullmann, B., Coubeils, J.L., Courriere, Ph., Gervois, J.P.: Quantum mechanical study of the conformational properties of phenethylamines of biochemical and medicinal interest. J. Med. Chem. 15, 17–23 (1972)

    Google Scholar 

  • Rand, M.J., Mc Culloch, M.W., Story, D.F.: Pre-junctional modulation of noradrenergic transmission by noradrenaline, dopamine and acetylcholine. In: Central Action of Drugs in Blood Pressure Regulation. Davies, D., Reid, J.L. (eds.). Tunbridge Wells: Pitman Medical Publishing 1975, pp. 94–132

    Google Scholar 

  • Rand, M.J., Wilson, J.: Mechanisms of the pressor and depressor actions of St 1 55 (2-(2, 6-dichlorphenylamino)-2-imidazoline-hydrochloride, Catapresan). Eur. J. Pharmacol. 3, 27–33 (1968)

    Google Scholar 

  • Reid, J.L., Briant, R.H., Dollery, C.T.: Desmethylimipramine and the hypotensive action of clonidine in the rabbit. Life Sci. 12, 459–467 (1973)

    Google Scholar 

  • Reid, J.L., Wing, L.M.H., Mathias, C.J., Frankel, H.L.: The central hypotensive action of clonidine in man: Studies in subjects with traumatic cervical spinal cord transection. Abstract of Paper Presented at the Eur. Soc. of Clinical Investigation, Rotterdam, 1976

    Google Scholar 

  • Robson, R.D., Kaplan, H.R.: An involvement of St 155 (2-(2, 6-dichlorphenylamino)-2-imidazoline hydrochloride, Catapres) in cholinergic mechanisms. Eur. J. Pharmacol. 5, 328–337 (1969)

    Google Scholar 

  • Robson, R.D., Kaplan, H.R., Laforce, S.: An investigation into the bradycardiac effects of St 155 (2-(2, 6-dichlorphenylamino)-2-imidazoline HC1 in the anaesthetised dog. J. Pharmacol. Exp. Ther. 169, 120–131 (1969)

    Google Scholar 

  • Rochette, L., Bralet, J.: Effect of clonidine on the synthesis of central dopamine. Biochem. Pharmacol. 24, 303–305 (1975)

    Google Scholar 

  • van Rossum, J.M.: Different types of sympathomimetic a-receptors. J. Pharm. Pharmacol. 17, 202–216 (1965)

    Google Scholar 

  • Rouot, B., Leclerc, G., Wermuth, C.-G.: Structure de la clonidine. Chim. Ther. 5, 545–551, (1973)

    Google Scholar 

  • Rouot, B., Leclerc, G., Wermuth, C.-G., Miesch, F., Schwartz, J.: Clonidine and related analogues. Quantitative correlations. J. Med. Chem. (in press) (1976)

    Google Scholar 

  • Rubenson, A.: Further studies on the mechanism of the central hypotensive effect of α-dopa, dl-in-tyrosine and 1-α-methyldopa. J. Pharm. Pharmacol. 23, 228–230 (1971a)

    Google Scholar 

  • Rubenson, A.: Analysis of the action of m-tyrosine on blood pressure in the conscious rat: evidence for a central hypotensive effect. J. Pharm. Pharmacol. 23, 412–419 (1971b)

    Google Scholar 

  • Saameli, K., Scholtysik, G., Waite, R.: Pharmacology of BS 100-141, a centrally acting antihypertensive drug. Clin. exper. Pharmacol. Physiol. (Suppl.) 2, 207–212 (1975)

    Google Scholar 

  • Sannerstedt, R., Conway, J.: Hemodynamic and vascular responses to antihypertensive treatment with adrenergic blocking agents: a review. Am. Heart J., 79, 122–127 (1970)

    Google Scholar 

  • Sattler, R.W., van Zwieten, P.A.: Acute hypotensive action of 2-(2, 6-dichlorphenylami-no)-2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery. Eur. J. Pharmacol. 2, 9–13 (1967)

    Google Scholar 

  • Schmitt, H.: Actions des alpha-sympathomimétiques sur les structures nerveuses. Actual. Pharmacol. (Paris) 24, 93–113 (1971)

    Google Scholar 

  • Schmitt, H.: On some unexplained effects of clonidine. In: Recent Advances in Hyperten-sion. Milliez, P., Safar, M. (eds.). Reims: Boehringer Ingelheim 1975, Vol. II, pp. 63–72

    Google Scholar 

  • Schmitt, H., Fénard, S.: Effets des substances sympathomimétiques sur les centres vaso-moteurs. Arch. Int. Pharmacodyn. 190, 229–240 (1971)

    Google Scholar 

  • Schmitt, H., Fournadjiev, G., Schmitt, H.: Central and peripheral effects of 2-(2, 6-dime-thylphenylamino)-4-H-5, 6-dihydro-l, 3-thiazin (Bayer 1470) on the sympathetic system. Eur. J. Pharmacol. 10, 230–238 (1970)

    Google Scholar 

  • Schmitt, H., Schmitt, H.: Localization of the hypotensive effect of 2-(2, 6-dichlorpheny-lamino)-2-imidazoline hydrochloride (St 155, Catapresan). Eur. J. Pharmacol. 6, 8–12 (1969)

    Google Scholar 

  • Schmitt, H., Schmitt, H.: Interactions between 2-(2, 6-dichlorophenylamino)-2-imidazo-line hydrochloride (St 155, catapresan R) and α-adrenergic blocking drugs. Eur. J. Pharmacol. 9, 7–13 (1970)

    Google Scholar 

  • Schmitt, H., Schmitt, H., Boissier, J.R., Giudicelli, J.F.: Centrally mediated decrease in sympathetic tone induced by 2-(2, 6-dichlorphenylamino)-2-imidazoline (St 155, Catapresan). Eur. J. Pharmacol. 2, 147–148 (1967)

    Google Scholar 

  • Schmitt, H., Schmitt, H., Boissier, J.R., Guidicelli, J.F., Fichelle, J.: Cardiovascular effects of 2-(2, 6-dichlorphenylamino)-2-imidazoline hydrochloride (St 155). II. Central sympathetic structures. Eur. J. Pharmacol. 2, 340 (1968)

    Google Scholar 

  • Schmitt, H., Schmitt, H., Fenard, S.: Evidence for an α-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane. Eur. J. Pharmacol. 14, 98–100 (1971)

    Google Scholar 

  • Schmitt, H., Schmitt, H., Fenard, S.: Decrease in the sympatho-inhibitory action of clonidine after destruction of the sympatho-inhibitory area. Experientia 29, 1247–1249 (1973a)

    Google Scholar 

  • Schmitt, H., Schmitt, H., Fenard, S.: Action of α-adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine. Arzneim. Forsch. 23, 40–45 (1973b)

    Google Scholar 

  • Schmitt, H., Schmitt, H., Fenard, S.: A technique for recording sympathetic nerve activity in unanaesthetized dogs. Neuropharmacology 13, 347–351 (1974)

    Google Scholar 

  • Scholtysik, G., Lauener, H., Eichenberger, E., Bürki, H., Salzmann, R., Müller-Schweinitzer, E., Waite, R.: Pharmacological actions of the antihypertensive agent N-amino-2-(-2, 6-dichlorphenyl) acetamide hydrochloride (BS 100-141). Arzneim. Forsch. 25, 1483–1491 (1975)

    Google Scholar 

  • Schwartz, A., Banach, S., Smith, J.S., Kim, K.E., Onesti, G., Swartz, Ch.: Clinical efficacy of clonidine in hypertension. In: Hypertension; Mechanisms and Management. Onesti, G., Kim, K.E., Moyer, J.H. (eds.). New York: Grune & Stratton 1973, pp. 389–394

    Google Scholar 

  • Scriabine, A., Stavorski, J., Wenger, H.C., Torchiana, M.L., Stone, C.A.: Cardiac slowing effects of clonidine (St 155) in dogs. J. Pharmacol. Exp. Ther. 171, 256–264 (1970)

    Google Scholar 

  • Seller, H., Illert, M.: The localization of the first synapse in the carotid sinus barorecep-tor reflex pathway and its alteration of the afferent input. Pflüegers Arch. 306, 1–19 (1969)

    Google Scholar 

  • Shaw, J., Hunyor, S.N., Korner, P.J.: Sites of central nervous action of clonidine on reflex autonomic function in the unanaesthetized rabbit. Eur. J. Pharmacol. 15, 66–78 (1971)

    Google Scholar 

  • Sherman, G.P., Grega, G.J., Woods, R.J., Buckley, J.P.: Evidence for a central hypotensive mechanism of 2-(2,6-dichlorphenylamino)-2-imidazoline (Catapresan, St 155). Eur. J. Pharmacol. 2, 326–328 (1969)

    Google Scholar 

  • Sinha, J.N., Atkinson, J.M., Schmitt, H.: Effects of clonidine and 1-DOPA on spontaneous and evoked splanchnic nerve discharges. Eur. J. Pharmacol. 24, 113–119 (1973)

    Google Scholar 

  • Sinha, J.N., Schmitt, H.: Central sympatho-inhibitory effects of intracisternal and intravenous administrations of noradrenaline in high doses. Eur. J. Pharmacol. 28 217–221 (1974)

    Google Scholar 

  • Sjoerdsma, A.: The central action of α-methyldopa and clonidine. In: Central Action of Drugs in Blood Pressure Regulation. Davies, D., Reid, J.L.. (eds.). Tunbridge Wells: Pitman Medical Publishing 1975, pp. 154–156

    Google Scholar 

  • Stähle, H.: See patent application, C.H. Boehringer Sohn, Chem. Abstr. 64, 2096e (1966)

    Google Scholar 

  • Stähle, H.: Medicinal chemistry related to the central regulation of blood pressure. I. Chemical part. In: Medicinal Chemistry IV. Maas, J. (ed.). Amsterdam-Oxford-New York: Elsevier Scientific Publishing 1974, pp. 75–105

    Google Scholar 

  • Stähle, H., Pook, K.-H.: Synthesen in der 2-Amino-imidazolin-Reihe. Liebigs Ann. Chem. 751, 159–167 (1971)

    Google Scholar 

  • Stähle, H., Pook, K.-H.: 55th Chem. Conference of the Chem. Inst. of Canada, Université Laval, Quebec, 1972

    Google Scholar 

  • Starke, K.: Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart. Naunyn Schmiedebergs Arch. Pharmacol. 274, 18–45 (1972)

    Google Scholar 

  • Starke, K.: Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77, 1–124 (1977)

    Google Scholar 

  • Starke, K., Endo, T., Taube, H.D.: Relative pre-and post-synaptic potencies of α-adreno-ceptor agonists in the rabbit pulmonary artery. Nauyn Schmiedebergs Arch. Pharmacol. 291, 55–78 (1975)

    Google Scholar 

  • Starke, K., Montel, H.: Involvement of alpha-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones. Neuropharmacology 12, 1073–1080 (1973)

    Google Scholar 

  • Starke, K., Montel, H., Gayk, W., Merker, R.: Comparison of the effects of clonidine on pre-and postsynaptic adrenoceptors in the rabbit pulmonary artery. Naunyn Schmiedebergs Arch. Pharmacol. 285, 133–150 (1974)

    Google Scholar 

  • Starke, K., Schumann, H.J.: Zur peripheren sympathicus-hemmenden Wirkung des Cloni-dins. Experientia 27, 70–71 (1971)

    Google Scholar 

  • Starke, K., Wagner, J., Schümann, H.J.: Adrenergic neuron blockade by clonidine: comparison with guanethidine and local anaesthetics. Arch. Int. Pharmacodyn. 195, 291–308 (1972)

    Google Scholar 

  • Stjärne, L.: Clonidine enhances the secretion of sympathetic neurotransmitter from isolated guinea-pig tissues. Acta Physiol. Scand. 93, 142 (1975)

    Google Scholar 

  • Strömbom, U.: Catecholamine receptor agonists. Effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Nauyn Schmiedebergs Arch. Pharmacol. 292, 167–176 (1976)

    Google Scholar 

  • Struyker Boudier, H.A.J.: Catecholamine receptors in nervous tissue. Relevance of neuro-nal catecholamine receptors in the mode of action of dopaminergic and antihyper-tensive drugs. Thesis, Nijmegen: Stichting Studentenpers., 1975

    Google Scholar 

  • Struyker Boudier, H.A.J., de Boer, J., Smeets, G., Lien, E.J., van Rossum, J.: Structure activity relationship for central and peripheral alpha adrenergic activities of imidazo-line derivatives. Life Sci. 17, 377–386 (1975a)

    Google Scholar 

  • Struyker Boudier, H., van Rossum, J.M.: Clonidine-induced cardiovascular effects after stereotaxic application in the hypothalamus of rats. J. Pharm. Pharmacol. 24, 410–411 (1972)

    Google Scholar 

  • Struyker Boudier, H.A.J., van Rossum, J.M., De Schaepdryver, A.F. (eds.): Essays on blood pressure control. Proceedings of an International Symposium on Hypertension, Nijmegen, 1974. Published by the Arch. Int. Pharmacodyn. (1975b)

    Google Scholar 

  • Struyker Boudier, H.A.J., Smeets, G.W.M., Brower, G.M., van Rossum, J.M.: Hypothala-mic alpha adrenergic receptors in cardiovascular regulation. Neuropharmacology 13, 837–846 (1974a)

    Google Scholar 

  • Struyker Boudier, H.A.J., Smeets, G.W.M., Brower, G.M., van Rossum, J.M.: Central and peripheral alpha adrenergic activity of imidazoline derivatives. Life Sci. 15, 887–899 (1974b)

    Google Scholar 

  • Svensson, T.H., Bunney, B.S., Aghajanian, G.K.: Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res., 92, 291–306 (1975)

    Google Scholar 

  • Tauberger, G., Kuhn, P.: Untersuchungen der zentralnerv ösen sympathicusdämpfenden Wirkungen von α-Methyl-dopa. Naunyn Schmiedebergs Arch. Pharmacol. 268, 33–43 (1971)

    Google Scholar 

  • Timmermans, P.B.U.W.U.: Clonidine (catapresanR)and structurally related imidazolines. Central hypotensive and antihypertensive activities; a structure-activity relationship study. Academische Pers., Amsterdam, 1976

    Google Scholar 

  • Toda, N., Fukuda, N., Shimamoto, K.: The mode of hypotensive actions of 2-(2,6-dichlor-phenyl-1-amino) imidazoline in the rabbit. Jpn. J. Pharmacol. 19, 199–210 (1969)

    Google Scholar 

  • Trendelenburg, U.: Supersensitivity and subsensitivity to sympathomimetic agents. Pharmacol. Rev. 15, 225–276 (1963)

    Google Scholar 

  • Trolin, G.: Effects of pentobarbitone and decerebration on the clonidine induced circulatory changes. Eur. J. Pharmacol. 34, 1–7 (1975)

    Google Scholar 

  • Ungerstedt, U.: Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol. Scand. (Suppl.) 367, 1–48 (1971)

    Google Scholar 

  • Uvnäs, B.: Central cardiovascular control. In: Handbook of Physiology, Section 1: Neurophysiology. Washington: American Physiological Society 1960, Vol. II, pp. 1131–1162

    Google Scholar 

  • Vizi, E.S., Somogyi, G.T., Hadházy, P., Knoll, J.: Effect of duration and frequency of stimulation on the presynaptic inhibition by α-adrenoceptor stimulation of the adrenergic transmission. Naunyn Schmiedebergs Arch. Pharmacol. 280, 79–91 (1973)

    Google Scholar 

  • Vorburger, C., Butikofer, E., Reubi, F.: Die akute Wirkung von St 155 auf die cardiale und renale Haemodynamik. In: Hochdrucktherapie. Heilmeyer, L., Holtmeier, H.-J., Pfeiffer, E.F. (eds.). Stuttgart: Georg Thieme Verlag, 1968, pp. 86–94

    Google Scholar 

  • Waite, R.: Inhibition of sympathetic nerve activity resulting from central alpha-adreno-ceptor stimulation. In: Recent Advances in Hypertension. Milliez, P., Safar, M. (eds.). Reims: Boehringer Ingelheim 1975, Vol. II, pp. 27–32

    Google Scholar 

  • Walland, A., Kobinger, W., Csongrady, A.: Action of clonidine on baroreceptor reflexes in conscious dogs. Eur. J. Pharmacol. 26, 184–190 (1974)

    Google Scholar 

  • Wermuth, C.G., Schwartz, J., Leclerc, G., Gamier, J.P., Rout, B.: Conformation de la clonidine et hypotheses sur son interaction avec un récepteur α-adrénergique. Chim. Thér. 1, 115–116 (1973)

    Google Scholar 

  • Werner, U., Starke, K., Schumann, H.J.: Actions of clonidine and 2-(2-methyl-6-ethyl-cyclohexylamino)-2-oxazoline on postganglionic autonomic nerves. Arch. Int. Pharmacodyn. 195, 282–290 (1972)

    Google Scholar 

  • Wing, L.M.H., Davies, D.S., Reid, J.L., Dollery, C.T.: Clonidine overdose. Br. Med. J. 4, 408–409 (1975)

    Google Scholar 

  • Zaimis, E., Hanington, E.: A possible pharmacological approach to migraine. Lancet 1969/II, 298–300

    Google Scholar 

  • van Zwieten, P.A.: Antihypertensive drugs with a central action. Prog. Pharmacol. Stuttgart: Gustav Fischer Verlag 1975, Vol. I, No. 1

    Google Scholar 

  • van Zwieten, P.A.: Centrally induced hypotension by 2-(2,6-dichlorphenyl)-5,6-dihy-droimidazo (2,1-b)-thiazole fumarate (compound 44-549) Pharmacology 13, 352–355

    Google Scholar 

  • van Zwieten, P.A.: Reduction of the hypotensive effect of clonidine and alpha-methyl-dopa by various psychotropic drugs. Clin. Sci. Molec. Med. 51, 411–413 (1976)

    Google Scholar 

  • van Zwieten, P.A., Pauer, M., van Spanning, H.W., DE Langen, C.: Interaction between centrally acting hypotensive drugs and tricyclic antidepressants. Arch. Int. Pharmacodyn. 214, 12–30 (1975)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ernst Boehringer Institut fur Arzneimittelforschung, Dr. Boehringer-Gasse 5-11, 1120, Wien, Austria

    Walter Kobinger

Authors
  1. Walter Kobinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Springer-Verlag

About this chapter

Cite this chapter

Kobinger, W. (1978). Central α-adrenergic systems as targets for hypotensive drugs. In: Reviews of Physiology, Biochemistry and Pharmacology, Volume 81. Reviews of Physiology, Biochemistry and Pharmacology, vol 81. Springer, Berlin, Heidelberg. https://doi.org/10.1007/BFb0034091

Download citation

  • DOI: https://doi.org/10.1007/BFb0034091

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-08554-6

  • Online ISBN: 978-3-540-35967-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation